INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  4. 04SJSheena Jonathan0B / 57S57 trades$3.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,500 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
HY
Howze YalondaCHIEF LEGAL OFFICER
GBIOGeneration Bio Co.
Option exercise
M—
335 sh
Jan 15, 2026Jan 16, 2026
Page 1465 of 1813
← PrevNext →
traded Jan 15, 2026
+1d
SEC Form 4

Evidence

17
OE
Osterhout Jeannette EEVP & CFO
OMFOneMain Holdings, Inc.
Grant or award
A—
26.4K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

16
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
3,000 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

16
GN
Gooden NathanDirector
LZLEGALZOOM.COM, INC.
Grant or award
A$67K
6,667 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

16
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$280K
600 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

15
HL
Hsieh Anthony LiDirector, Executive Chair, CEO & Pres., 10% Owner
LDIloanDepot, Inc.
Open-market sale · 10b5-1 plan
SELL$1.10M
415.5K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

15
OL
Oseland Robert LChief Operating Officer
MYPSPLAYSTUDIOS, Inc.
Option exercise
M—
125.0K sh
Jan 13, 2026Jan 16, 2026
traded Jan 13, 2026
+3dSEC Form 4

Evidence

15
AJ
Argen JohnDirector
DTSTData Storage Corp
Disposition to issuer
D$297K
57.2K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

15
OL
Oseland Robert LChief Operating Officer
MYPSPLAYSTUDIOS, Inc.
Option exercise
M—
141.7K sh
Jan 13, 2026Jan 16, 2026
traded Jan 13, 2026
+3dSEC Form 4

Evidence

15
OC
O'Kelly CiaranDirector
UPSTUpstart Holdings, Inc.
Grant or award
A—
1,168 sh
Jan 12, 2026Jan 16, 2026
traded Jan 12, 2026
+4dSEC Form 4

Evidence

14
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$372K
5,427 sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

14
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale
SELL$5,529
30.0K sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

14
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$968K
14.4K sh
Jan 16, 2026Jan 16, 2026
traded Jan 16, 2026
+0dSEC Form 4

Evidence

14
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
1,045 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

13
HY
Howze YalondaCHIEF LEGAL OFFICER
GBIOGeneration Bio Co.
Option exercise
M—
335 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
GD
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
BDXBECTON DICKINSON & CO
Option exercise · 10b5-1 plan
M$513K
3,054 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
MM
Mercier MattCFO
DLRDIGITAL REALTY TRUST, L.P.
Grant or award
A—
6,896 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
160 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$56K
120 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$145K
320 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
MM
Mercier MattCFO
DLRDIGITAL REALTY TRUST, INC.
Grant or award
A—
6,896 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
GD
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
BDXBECTON DICKINSON & CO
Disposition to issuer · 10b5-1 plan
D$513K
2,454 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$108K
240 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
160 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
DA
D'Amico AndrewDirector
VICRVICOR CORP
Open-market sale · 10b5-1 plan
SELL$30K
200 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$186K
400 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
DD
Devaisher Len DPresident and COO
MOFGMidWestOne Financial Group, Inc.
Grant or award
A—
2,131 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
SL
Sims Gary LSVP & Chief Credit Officer
MOFGMidWestOne Financial Group, Inc.
Grant or award
A—
1,066 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
ET
Edekar Edmundson TinaDirector
MLKNMILLERKNOLL, INC.
Option exercise
M$12K
616 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$168K
360 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
MJ
Mahoney Robert JohnEVP Global Operations
ACLSAXCELIS TECHNOLOGIES INC
Grant or award
A—
1,734 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
LJ
Lee JeannieEVP, GENERAL COUNSEL
DLRDIGITAL REALTY TRUST, INC.
Grant or award
A—
4,598 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
LJ
Lee JeannieEVP, GENERAL COUNSEL
DLRDIGITAL REALTY TRUST, L.P.
Grant or award
A—
4,598 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
FJ
Flower JohannaDirector
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$110K
240 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

13
CR
Conrad Micah R.EVP & COO
OMFOneMain Holdings, Inc.
Grant or award
A—
31.5K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

12
NS
Narayan ShruthiPresident
PENPenumbra Inc
Tax withholding
F$100K
286 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

12
MA
Marathe AjayChief Operating Officer
ENVXEnovix Corp
Tax withholding
F$66K
8,087 sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

12
MA
Maglione Lawrence A.Director
DTSTData Storage Corp
Disposition to issuer
D$129K
24.8K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence

12
GD
Garrison Michael DavidEVP & Pres Med.Essntl&BioPharm
BDXBECTON DICKINSON & CO
Open-market sale · 10b5-1 plan
SELL$209K
1,010 sh
Jan 15, 2026Jan 16, 2026
traded Jan 15, 2026
+1dSEC Form 4

Evidence

11
BL
Burroughs Amy L.Director, Chief Executive Officer
TERNTerns Pharmaceuticals, Inc.
Grant or award · 10b5-1 plan
A—
150.0K sh
Jan 14, 2026Jan 16, 2026
traded Jan 14, 2026
+2dSEC Form 4

Evidence